November 19th 2024
Muvalaplin, an oral treatment, reduced Lp(a) by up to 85% in a 12-week Phase 2 trial presented at AHA 2024.
Surprising Findings in Genetic Analysis of Familial Hypercholesterolemia Patients
A large genetic analysis showed that the incidence of a single genetic mutation in familial hypercholesterolemia patients is smaller than thought--but that those who do have the mutation face a far higher risk of heart disease.
Racial Disparities in Cardiovascular Events from Rheumatoid Arthritis
February 5th 2016Connective tissue disease (CTD) groups together various disorders, such as rheumatoid arthritis and lupus. A new study from the University of Chicago found that complications from these diseases are more prominent based on race.
Treating the Adolescent Endocrine Patient a Delicate Process
February 3rd 2016Teenagers can be tricky patients to treat. Parents know that, patients who progress through the adolescent years and reflect on their teen years know that, and increasingly, organized medicine is acknowledging it with structured specialties in adolescent medicine. Endocrinologists who treat adolescents need unique communication skills and plenty of patience.